Vascular Biogenics Ltd. - Ordinary Shares (VBLT): Price and Financial Metrics

VBLT POWR Grades

• Sentiment is the dimension where VBLT ranks best; there it ranks ahead of 97.98% of US stocks.
• The strongest trend for VBLT is in Sentiment, which has been heading up over the past 138 days.
• VBLT's current lowest rank is in the Momentum metric (where it is better than 4.75% of US stocks).

VBLT Stock Summary

• Vascular Biogenics Ltd's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 7.44% of US listed stocks.
• With a price/sales ratio of 157.97, Vascular Biogenics Ltd has a higher such ratio than 98.25% of stocks in our set.
• Revenue growth over the past 12 months for Vascular Biogenics Ltd comes in at -16.7%, a number that bests only 8.1% of the US stocks we're tracking.
• Stocks that are quantitatively similar to VBLT, based on their financial statements, market capitalization, and price volatility, are VTGN, AYLA, GNCA, STTK, and SGTX.
• VBLT's SEC filings can be seen here. And to visit Vascular Biogenics Ltd's official web site, go to www.vblrx.com.

VBLT Valuation Summary

• VBLT's price/sales ratio is 186.4; this is 1542.29% higher than that of the median Healthcare stock.
• VBLT's price/sales ratio has moved NA NA over the prior 84 months.
• VBLT's EV/EBIT ratio has moved up 3.9 over the prior 84 months.

Below are key valuation metrics over time for VBLT.

VBLT Growth Metrics

The year over year price growth rate now stands at 68.33%.
• Its year over year revenue growth rate is now at 4.51%.
• Its 4 year price growth rate is now at -63.75%.

Over the past 30 months, VBLT's revenue has gone up $136,000.

The table below shows VBLT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	0.777	-25.545	-28.07
2021-06-30	0.771	-22.289	-27.345
2021-03-31	0.741	-23.552	-25.155
2020-12-31	0.922	-23.378	-24.225
2020-09-30	0.843	-19.831	-22.697
2020-06-30	0.729	-19.999	-21.776

VBLT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VBLT has a Quality Grade of C, ranking ahead of 42.6% of graded US stocks.
• VBLT's asset turnover comes in at 0.015 -- ranking 380th of 682 Pharmaceutical Products stocks.
• ISEE, SRNE, and CNCE are the stocks whose asset turnover ratios are most correlated with VBLT.

The table below shows VBLT's key quality metrics over time.